56619-93-3 Usage
Description
N-(3-Methoxyphenyl)-2,2-dimethylpropanamide, a chemical compound with the molecular formula C13H19NO2, is a white to off-white solid substance. It serves as an intermediate in the synthesis of pharmaceuticals and agrochemicals, known for its analgesic and anti-inflammatory properties, which make it a potential candidate for developing new pain-relief medications. Additionally, it is utilized as a building block in the production of various drugs and biologically active compounds. Due to its potential risks to human health and the environment, it is typically handled and stored in a controlled environment.
Uses
Used in Pharmaceutical Industry:
N-(3-Methoxyphenyl)-2,2-dimethylpropanamide is used as an intermediate in the synthesis of pharmaceuticals for its analgesic and anti-inflammatory properties, contributing to the development of new pain-relief medications.
Used in Agrochemical Industry:
In the agrochemical sector, N-(3-Methoxyphenyl)-2,2-dimethylpropanamide is employed as an intermediate in the synthesis of agrochemicals, potentially enhancing crop protection and yield.
Used in Drug Development:
N-(3-Methoxyphenyl)-2,2-dimethylpropanamide is used as a building block in the production of various drugs and biologically active compounds, facilitating the creation of innovative therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 56619-93-3 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 5,6,6,1 and 9 respectively; the second part has 2 digits, 9 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 56619-93:
(7*5)+(6*6)+(5*6)+(4*1)+(3*9)+(2*9)+(1*3)=153
153 % 10 = 3
So 56619-93-3 is a valid CAS Registry Number.
InChI:InChI=1/C12H17NO2/c1-12(2,3)11(14)13-9-6-5-7-10(8-9)15-4/h5-8H,1-4H3,(H,13,14)
56619-93-3Relevant articles and documents
COMPOUNDS, PHARMACEUTICAL COMPOSITIONS, AND METHODS OF PREPARING COMPOUNDS AND OF THEIR USE
-
Page/Page column 76; 136, (2021/10/11)
Disclosed are compounds and pharmaceutically acceptable salts thereof that may be used in the treatment of subjects in need thereof. The compounds disclosed herein may be inhibitors of tyrosine and threonine-specific cdc2-inhibitory kinase (Myt1). Also di
Ligand Promoted Olefination of Anilides for Indirectly Introducing Fluorinated Functional Groups via Palladium Catalyst
Wang, Dongjie,Xu, Xu,Zhang, Jingyu,Zhao, Yingsheng
, p. 2696 - 2705 (2021/02/27)
We report a palladium-catalyzed, ligand promoted, C-H fluorine-containing olefination of anilides with 4-bromo-3,3,4,4-tetrafluorobutene as the fluorinated reagent, which has a potential transformation into other compounds due to its -CF2CF2Br functional group. -CF2CF2H was obtained by using the mild reducing agent sodium borohydride. Bioactive compounds such as aminoglutethimide derivative and propham were well-tolerated in this reaction, both of which highlight the synthetic importance of this method.
Palladium(II)-Catalyzed Oxidative Homo- and Cross-Coupling of Aryl ortho -sp2 C-H Bonds of Anilides at Room Temperature
Mei, Chong,Lu, Wenjun
, p. 4812 - 4823 (2018/04/26)
The preparation of secondary 2,2'-bisanilides has been successfully achieved through an oxidative coupling of aryl ortho-sp2 C-H bonds of anilides in the presence of catalytic Pd(OAc)2 and K2S2O8 as an oxidant in MsOH/CF3CO2H (TFA) at room temperature (25 °C). The aromatic rings of anilides substituted by various electron-donating or electron-withdrawing groups are tolerant in these coupling reactions.